Vancomycin-resistant van a phenotype Enterococcus faecalis: First case in Minas Gerais state and epidemiological considerations

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 4, 2007, Pages 439-440

  Ribas, Rosineide Marques ^a,c   da Costa Darini, Ana Lúcia ^b   Moreira, Tomaz Aquino ^a   Freitas, Claudete ^a   Gontijo Filho, Paulo P ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NONE   (Brazil)

Author keywords

Antibiotic resistance; Nosocomial infections; VRE

Indexed keywords

BACTERIAL PROTEIN; CEFALOTIN; CEFTRIAXONE; GENTAMICIN; LINEZOLID; STREPTOMYCIN; UNCLASSIFIED DRUG; VANA PROTEIN; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLADDER RECONSTRUCTION; BRAZIL; CASE REPORT; DISEASE SURVEILLANCE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENTEROCOCCUS FAECALIS; FEMALE; GENERAL HOSPITAL; GENOTYPE PHENOTYPE CORRELATION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; OSTEOSYNTHESIS; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; SURGICAL PATIENT; TRAFFIC ACCIDENT; UNIVERSITY HOSPITAL; URINARY TRACT INFECTION; URINE CULTURE; BACTERIAL INFECTION; CROSS INFECTION; DRUG EFFECT; GENETICS; GENOTYPE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHENOTYPE;

ACETAMIDES; ADULT; ANTI-INFECTIVE AGENTS; BRAZIL; CROSS INFECTION; ENTEROCOCCUS FAECALIS; FEMALE; GENOTYPE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; PHENOTYPE; VANCOMYCIN RESISTANCE;

EID: 34948884007     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000400015     Document Type: Article

References (21)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am. J. Infect Control 2004;32:470-85.
2. Diekema D.J., BootsMiller B.J., Vaughn E.V., et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. 2004:38:78-84.
3. Brown D.F.J., Brown N.M., Bookson B.D., et al., National glycopeptide-resistant enterococcal bacteraemia surveillance working group report to the Department o Health - august 2004. J Hosp Inf 2006;62(Suppl 1):S1-S27.
4. Dalla Costa L.M., Souza D.C., Martins L.T.F., et al. Vancomycin-resistant Enterococcus faecium: first case in Brazil. Braz J Infect Dis 1998:2:160-3.
5. Camargo I.L., Del Peloso P.F., Da Costa Leite C.F., et al. Identification of an unusual VanA element in glycopeptide-resistant Enterococcus faecium in Brazil following international transfer of a bone marrow transplant patient. Can J Microbiol 2004; 50:767-70.
6. Zanella R.C.; Valdetaro F., Lovgren M., et al. First confirmed case of a vancomycin-resistant Enterococcus faecium with vanA phenotype from Brazil: isolation from a meningitis case in São Paulo. Microb Drug Resist 1999;5:159-62.
7. Zervos M.J., Terpenning M.S., Schaber D.R., et al. High level aminoglycoside-resistant enterococci-colonization of nursing home and acute care hospital patients. Arch Intern Med 1987:1591-4.
8. Rhinehart E., Smith N.E., Wennersten C., et al. Rapid dissemination of b-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among, patients and staff on an infant-toddler surgical ward. N Engl J Med 1990;323:1814-8.
9. Clark N.C., Cooksey E.C., Hill B.C., et al. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob. Agents Chemother 1993;37:2311-7.
10. Husni R., Haschem R., Hanna H. Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 2002;23:102-3.
11. Handwerger S., Raucher B., Altarac D., et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin Infect Djis 1993;16:750-5.
12. Byers K.E., Anglim A M., Anneski C.J., et al. A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control. Infect Control Hosp Epidemiol 2001;22:140-7.
13. Gerding D.N. Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 1997;25(Supppl 2):206-10.
14. Montecalvo M.A., de Lencastre H., Carraher M., et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16:680-5.
15. Livornese L.L., Dias S., Samel C., et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112-6.
16. Goossens H. Spread of vancomycin-resistant enterococci: differences between United States and Europe. Infect control Hosp Epidemio 1998;19:546-51.
17. Bates J. Epidemiology of vancomycin-resistant enterocci in the community and the relevance of farm animals to human infection. J Hosp Infect 1997;37:89-101.
18. Endtz H.P., van den Braak N., van Belkim A., et al. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol 1997; 35:3026-31.
19. Silva C.R.M. Pesquisa de enterococcus resistente aos glicopeptídeos em humanos, aves e ambiente, na cidade de Uberlândia. Dissertação de Mestrado. Curso de Pós-graduação em Genética e Bioquímica. Universidade Federal de Uberlândia, MG. 2000.
20. Couto H.G., Lelles C.C.V., Lima H.V., et al. Vancomycin use in a Brazilian University hospital: Comparisons with hospital infection control practices advisory committee guidelines. Braz J Infec Dis 1999;3:139-43.
21. Cereda R., Sader H., Sejas L., et al. Enterococcus faecalis resistant to vancomycin and teicoplanin (VanA phenotype) isolated from a bone marrow transplanted patient in Brazil. Braz J Infect Dis 2001;5(1):40-6.